María Paz Guerrero-Molina
5PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 04, 2024
Reply: assessing the effect of oral glutamine on the MELAS phenotype requires appropriate study designs.María Paz Guerrero-Molina, Jesús González de la Aleja
|Dec 19, 2023
Magnetic resonance spectroscopy in MELAS syndrome: correlation with CSF and plasma metabolite levels and change after glutamine supplementation.María Paz Guerrero-Molina, Ángela Bernabeu-Sanz, Ana Ramos-González
|Jan 16, 2023
Reply: High-dose oral glutamine can reduce cerebrospinal fluid glutamate in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes without a beneficial clinical or cerebral tissue effect.María Paz Guerrero-Molina, Cristina Domínguez-González, Jesús González de la Aleja
|Nov 05, 2022
High-dose oral glutamine supplementation reduces elevated glutamate levels in cerebrospinal fluid in patients with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes syndrome.María Paz Guerrero-Molina, Montserrat Morales-Conejo, Aitor Delmiro
|Jan 28, 2022
Elevated glutamate and decreased glutamine levels in the cerebrospinal fluid of patients with MELAS syndrome.María Paz Guerrero-Molina, Montserrat Morales-Conejo, Aitor Delmiro
Pageof 1
Frequent Collaborators
4 joint publications
Cristina Domínguez-González
4 joint publications
Jesús González de la Aleja
3 joint publications
Montserrat Morales-Conejo
3 joint publications
Aitor Delmiro
3 joint publications
Joaquín Arenas
3 joint publications
Miguel A Martín
2 joint publications
María Morán
1 joint publications
Ángela Bernabeu-Sanz
